Intervention Review

Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders

  1. Tamara Pringsheim1,*,
  2. Thomas Steeves2

Editorial Group: Cochrane Developmental, Psychosocial and Learning Problems Group

Published Online: 13 APR 2011

Assessed as up-to-date: 29 JAN 2010

DOI: 10.1002/14651858.CD007990.pub2

How to Cite

Pringsheim T, Steeves T. Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders. Cochrane Database of Systematic Reviews 2011, Issue 4. Art. No.: CD007990. DOI: 10.1002/14651858.CD007990.pub2.

Author Information

  1. 1

    University of Calgary, Clinical Assistant Professor, Department of Clinical Neurosciences and Pediatrics, Calgary, Alberta, Canada

  2. 2

    University of Toronto, Department of Medicine, Toronto, ON, Canada

*Tamara Pringsheim, Clinical Assistant Professor, Department of Clinical Neurosciences and Pediatrics, University of Calgary, Alberta Children's Hospital, C4-431, 2888 Shaganappi Trail NW, Calgary, Alberta, AB T3B 6A8, Canada. tmprings@ucalgary.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 13 APR 2011

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Michael H. Bloch, Daniel A. Gorman, Elia Abi-Jaoude, Commentaries on ‘Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders’, Evidence-Based Child Health: A Cochrane Review Journal, 2012, 7, 4
  2. 2
    Michael Venables, Evangelia Ntzani, Yingfen Hsia, Donna Gillies, Alpha2 adrenergic agonists for attention deficit hyperactivity disorder (ADHD), The Cochrane Library,
  3. 3
    G Kannan Kallapiran, Priya Mammen, Prathap Tharyan, Paul Russell, Atomoxetine for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents, The Cochrane Library,
  4. 4
    Ole Jakob Storebø, Maria Skoog, Dorte Damm, Per Hove Thomsen, Erik Simonsen, Christian Gluud, Social skills training for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years, The Cochrane Library,